Cerebrolysin
A brain-derived neuropeptide mixture studied for stroke recovery, dementia, and cognitive protection
Cerebrolysin is unlike most peptides on this site. It is not a single synthetic compound but a carefully prepared mixture of small peptides and amino acids derived from porcine (pig) brain tissue. Think of it as a concentrated extract of the brain's own repair signals. The manufacturing process breaks down brain proteins into tiny fragments that are small enough to cross the blood-brain barrier — the protective wall that keeps most substances out of the brain. Once inside, these fragments mimic the actions of the brain's own growth factors, the proteins that keep neurons alive, growing, and connected. It has been used clinically in Europe and Asia for decades and is one of the most studied neuroprotective agents in the world, though it remains unapproved in the United States.
Mechanism of action
Cerebrolysin works through several pathways at once. Its peptide fragments mimic the actions of natural neurotrophic factors — proteins like NGF and BDNF that your brain normally produces to keep neurons healthy and growing. Think of neurotrophic factors as fertilizer for your brain cells. Cerebrolysin also protects neurons from the damage caused by reduced blood flow (ischemia), overstimulation by neurotransmitters (excitotoxicity), and oxidative stress — three of the main ways neurons die after a stroke or injury. On top of that, it helps the brain use glucose more efficiently, which is important because the brain runs almost entirely on glucose for energy.
Benefits discussed in research
- Mimics nerve growth factor (NGF) and BDNF to support neuron survival
- Neuroprotection against stroke, ischemia, and brain injury
- Cognitive improvement in Alzheimer's and vascular dementia
- Promotes formation of new neurons (neurogenesis)
- Supports new synaptic connections (synaptogenesis)
- Improves glucose utilization and energy metabolism in the brain
- Anti-inflammatory effects in the central nervous system
- Studied for traumatic brain injury (TBI) recovery
Research status
Widely Used
Dosing information
For educational and research purposes only. Not medical advice.
- typical
- 5–10 mL per session (IV or IM)
- range
- 5–30 mL per session depending on condition
- frequency
- Daily for 10–20 days (course-based treatment)
- route
- Intravenous (IV) infusion or intramuscular (IM) injection
- cycleLength
- 10–20 day course, repeated 2–4 times per year
- notes
- Cerebrolysin is typically administered as a course rather than ongoing daily use. IV infusion is preferred for acute conditions (stroke, TBI) and provides faster onset. IM injection is used for maintenance and outpatient protocols. Dosing varies widely by condition: stroke protocols often use 30 mL/day IV for 10–21 days; cognitive enhancement protocols typically use 5–10 mL IM for 10 days. Always administered under medical supervision.
Side effects and safety
- Generally well tolerated with a good safety profile
- Headache (uncommon)
- Dizziness or lightheadedness
- Nausea
- Sweating
- Local injection site reactions
- Rare allergic reactions (biological product from animal tissue)
- Agitation or insomnia in some users (usually dose-dependent)
Frequently asked questions
What is Cerebrolysin made from?
Cerebrolysin is made from porcine (pig) brain tissue that goes through a carefully controlled enzymatic hydrolysis process. This breaks the brain proteins down into very small peptide fragments and free amino acids — small enough to pass through the blood-brain barrier. The process is standardized to ensure consistency and to remove large proteins and lipids that could cause immune reactions. The end result is a clear solution that contains hundreds of small bioactive peptides that mimic the brain's own growth and repair signals.
Is Cerebrolysin FDA approved?
No. Cerebrolysin is not approved by the FDA for any medical use in the United States. However, it is approved and widely used as a prescription medication in many countries across Europe, Asia, and Latin America — particularly for stroke recovery, dementia, and traumatic brain injury. The lack of FDA approval does not mean it is ineffective; it means the large-scale, independently funded clinical trials required for US approval have not been completed.
How is Cerebrolysin different from other cognitive peptides like Semax or Selank?
Semax and Selank are single synthetic peptides — one molecule with a specific, well-defined mechanism. Cerebrolysin is a complex mixture of hundreds of different small peptides and amino acids, all derived from actual brain tissue. Think of it this way: Semax is like a targeted drug, while Cerebrolysin is more like a broad-spectrum biological therapy. Cerebrolysin has a much larger body of clinical research behind it, especially for serious neurological conditions. Semax and Selank are more commonly used for cognitive enhancement in healthy people.
Can Cerebrolysin help with Alzheimer's disease?
There is clinical evidence suggesting benefit, but it is not a cure. Multiple trials, particularly from Europe and Asia, have shown improvements in cognitive function, memory, and daily living activities in Alzheimer's patients. However, Cochrane systematic reviews have noted that many of these studies had methodological limitations — small sample sizes, short durations, or potential for bias. The honest answer is: the evidence is promising but not yet definitive enough to call it a proven treatment. It is used clinically in many countries as part of a broader treatment approach.
What is the difference between IV and IM administration?
IV (intravenous) means the solution goes directly into a vein, usually through an infusion drip. This gets the peptides into your bloodstream immediately and is used for acute conditions like stroke or TBI where speed matters. IM (intramuscular) means the injection goes into a muscle, where it is absorbed more slowly over time. IM is more practical for outpatient use and maintenance protocols. Both routes are effective; IV is faster and used for higher doses, while IM is more convenient for ongoing treatment.
Is Cerebrolysin safe?
Cerebrolysin has a well-established safety profile based on decades of clinical use in multiple countries. The most common side effects are mild and temporary — headache, dizziness, nausea, and local injection site reactions. Because it is derived from animal tissue, there is a theoretical risk of allergic reactions, though these are rare. The main safety consideration is that it should always be administered under medical supervision, both because of the IV/IM administration route and because it is a biological product that requires proper handling and storage.
Research references
- Cerebrolysin for Acute Ischemic Stroke — Cochrane Review (2012)
- Cerebrolysin in Alzheimer's Disease: Systematic Review (2007)
- Cerebrolysin for Traumatic Brain Injury (2014)
- Neurotrophic Mechanisms of Cerebrolysin (2012)
Related peptides
- Semax
A nootropic peptide that enhances focus, memory, and neuroprotection
- Selank
A Russian anxiolytic peptide that reduces anxiety without sedation or dependence
- Methylene Blue
Mitochondrial electron carrier studied for cognitive enhancement and neuroprotection
- NAD+
The master coenzyme for cellular energy, DNA repair, and sirtuin-driven longevity